CL2017002549A1 - Use of a bismuth-thiol (bt) composition, which is used to prepare a medication useful for the treatment of an open wound that has or is at risk of having a bacterial biofilm infection. - Google Patents
Use of a bismuth-thiol (bt) composition, which is used to prepare a medication useful for the treatment of an open wound that has or is at risk of having a bacterial biofilm infection.Info
- Publication number
- CL2017002549A1 CL2017002549A1 CL2017002549A CL2017002549A CL2017002549A1 CL 2017002549 A1 CL2017002549 A1 CL 2017002549A1 CL 2017002549 A CL2017002549 A CL 2017002549A CL 2017002549 A CL2017002549 A CL 2017002549A CL 2017002549 A1 CL2017002549 A1 CL 2017002549A1
- Authority
- CL
- Chile
- Prior art keywords
- composition
- bismuth
- thiol
- risk
- prepare
- Prior art date
Links
- BIGYLAKFCGVRAN-UHFFFAOYSA-N 1,3,4-thiadiazolidine-2,5-dithione Chemical compound S=C1NNC(=S)S1 BIGYLAKFCGVRAN-UHFFFAOYSA-N 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 3
- 206010052428 Wound Diseases 0.000 title abstract 2
- 230000001580 bacterial effect Effects 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 239000011859 microparticle Substances 0.000 abstract 2
- 239000000725 suspension Substances 0.000 abstract 2
- -1 BT compound Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
- A01N55/02—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/82—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/29—Antimony or bismuth compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Otolaryngology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Zoology (AREA)
- Agronomy & Crop Science (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
<p>la invención divulga uso de una composición de bismuto-tiol (BT), CARACTERIZADO porque sirve para preparar un medicamento útil para el tratamiento de una herida abierta que tiene o que está en riesgo de tener una infección de biopelícula bacteriana, en donde la composición BT comprende una suspensión monodispersa de micropartículas que comprenden un compuesto de BT, en donde en dicha suspensión, al menos el 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% o 99% de dichas micropartículas tienen un diámetro volumétrico medio de aproximadamente 0,4 μm a aproximadamente 10μm.</p><p> The invention discloses the use of a bismuth-thiol (BT) composition, CHARACTERIZED because it serves to prepare a medicament useful for the treatment of an open wound that has or is at risk of having a bacterial biofilm infection, wherein The BT composition comprises a monodispersed suspension of microparticles comprising a BT compound, wherein in said suspension, at least 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96 %, 97%, 98% or 99% of said microparticles have an average volumetric diameter of about 0.4 µm to about 10μm. </p>
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37318810P | 2010-08-12 | 2010-08-12 | |
PCT/US2011/023549 WO2011097347A2 (en) | 2010-02-03 | 2011-02-03 | Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2017002549A1 true CL2017002549A1 (en) | 2018-05-11 |
Family
ID=44356067
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2013000430A CL2013000430A1 (en) | 2010-08-12 | 2013-02-12 | Method to protect a plant against a bacterial, fungal or viral pathogen because it comprises contacting the plant with bismuth thiol (bt); method for overcoming antibiotic resistance in a plant, in or on which a bacterial plant pathogen resistant to antibiotics is present. |
CL2017002549A CL2017002549A1 (en) | 2010-08-12 | 2017-10-10 | Use of a bismuth-thiol (bt) composition, which is used to prepare a medication useful for the treatment of an open wound that has or is at risk of having a bacterial biofilm infection. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2013000430A CL2013000430A1 (en) | 2010-08-12 | 2013-02-12 | Method to protect a plant against a bacterial, fungal or viral pathogen because it comprises contacting the plant with bismuth thiol (bt); method for overcoming antibiotic resistance in a plant, in or on which a bacterial plant pathogen resistant to antibiotics is present. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP2603083A4 (en) |
JP (7) | JP2013535506A (en) |
KR (6) | KR20200015814A (en) |
CN (2) | CN105766990B (en) |
AU (3) | AU2011289338B2 (en) |
BR (2) | BR112012019286A2 (en) |
CA (1) | CA2807993C (en) |
CL (2) | CL2013000430A1 (en) |
IL (3) | IL224684A (en) |
MX (4) | MX371047B (en) |
NZ (1) | NZ606634A (en) |
PH (1) | PH12016502498A1 (en) |
RU (2) | RU2018108411A (en) |
SG (3) | SG10201506131RA (en) |
UA (1) | UA113616C2 (en) |
WO (1) | WO2012021754A2 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9028878B2 (en) | 2009-02-03 | 2015-05-12 | Microbion Corporation | Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
US8389021B2 (en) | 2009-02-03 | 2013-03-05 | Microbion Corporation | Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications |
KR20200015814A (en) * | 2010-02-03 | 2020-02-12 | 마이크로비온 코포레이션 | Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
CN105307633B (en) * | 2013-03-18 | 2019-06-21 | 瑟拉诺维斯两合有限公司 | Oral care composition |
RU2525200C1 (en) * | 2013-04-09 | 2014-08-10 | Алексей Георгиевич Бородкин | Agent for protection and repair of wound of trees |
KR101703732B1 (en) * | 2013-11-07 | 2017-02-07 | (주)아모레퍼시픽 | Anti-inflammatory composition containing enzymated camellia japonica seed oil |
WO2017145142A1 (en) | 2016-02-25 | 2017-08-31 | Nobio Ltd. | Micro and nanoparticulate compositions comprising anti-microbially active groups |
EP3675802A4 (en) | 2017-08-30 | 2021-03-03 | Nobio Ltd. | Compositions and medical devices comprising anti-microbial particles |
CN107950536A (en) * | 2017-12-04 | 2018-04-24 | 刘志伟 | A kind of bactericidal composition containing Bravo |
CN108839186B (en) * | 2018-05-15 | 2021-02-26 | 阜南县金威工艺品有限公司 | Mildew-proof treatment method for mulberry twig woven product |
CN112788950A (en) | 2018-07-31 | 2021-05-11 | 微生物公司 | Bismuth-thiol compositions and methods for treating wounds |
US11464749B2 (en) | 2018-07-31 | 2022-10-11 | Microbion Corporation | Bismuth-thiol compositions and methods of use |
KR101990253B1 (en) * | 2018-11-22 | 2019-06-17 | 하봉호 | Container type mushroom growing apparatus |
CN109997856B (en) * | 2019-04-15 | 2020-11-03 | 广西大学 | Composition of small molecular compound and application thereof |
KR102126721B1 (en) * | 2019-07-16 | 2020-06-25 | (주)인트론바이오테크놀로지 | Novel Enterobacter aerogenes bacteriophage Ent-AEP-1 and its use for preventing proliferation of Enterobacter aerogenes and Enterobacter cloacae |
JP7458622B2 (en) * | 2019-09-18 | 2024-04-01 | 学校法人東京農業大学 | Substances that reduce the resistance of antibiotic-resistant microorganisms and methods for reducing the resistance of antibiotic-resistant microorganisms |
CN110663672B (en) * | 2019-11-13 | 2024-04-26 | 南京林业大学 | Thread-driven root pesticide application head |
US11479655B2 (en) | 2020-01-15 | 2022-10-25 | The Boeing Company | Compositions for use with polysulfide sealants and related methods |
KR102197719B1 (en) | 2020-05-07 | 2021-01-04 | 곽태진 | Cuttlefish breeding system |
CN111856546B (en) * | 2020-06-23 | 2022-07-29 | 中国辐射防护研究院 | Sample preparation method for radiochemical analysis of Cs-137 in marine organism ash |
CN113969300A (en) * | 2020-07-23 | 2022-01-25 | 启迪禾美生物科技(嘉兴)有限公司 | Eucalyptus leaf composite active extract process and antibacterial application thereof |
CN112640907B (en) * | 2021-01-19 | 2021-11-16 | 西南大学 | Novel application of lipoic acid in inhibiting plant fungal pathogenic bacteria and method for preventing and treating citrus fruit postharvest fungal diseases |
KR102431000B1 (en) * | 2021-07-22 | 2022-08-11 | 농업회사법인 주식회사 아그로비즈 | Composition for an autoimmune builder of plants containing aspirin and benzothiazole, and method of using the same |
EP4310192A1 (en) * | 2022-07-21 | 2024-01-24 | C4Diagnostics | Method of determining the existence and/or degree of resistance of microorganisms to antimicrobial agents |
CN115323778B (en) * | 2022-08-16 | 2023-07-18 | 汕头市润丰纺织科技实业有限公司 | Chitosan-I type collagen amino acid composite antibacterial finishing liquid, preparation method thereof and antibacterial fabric |
TR2022012983A2 (en) * | 2022-08-17 | 2022-09-21 | Marmara Ueniv Strateji Gelis Dai Bsk Muhasebe Birimi | A BIOCOMPATIBLE PRODUCT WITH REPRESENTATIVE AND THERAPEUTIC PROPERTIES FOR BONE DISORDERS AND/OR FRACTURES AND A METHOD FOR OBTAINING THE SUBJECT PRODUCT |
CN115532295B (en) * | 2022-09-27 | 2023-07-25 | 苏州大学 | Application of nanomaterial containing Zn-N-C active center in removal of bacterial biofilm |
KR102644907B1 (en) * | 2023-12-01 | 2024-03-07 | (주)신용이엔씨 | Eco-friendly grouting composition for ground reinforcement and method of manufacturing the same |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2809971A (en) * | 1955-11-22 | 1957-10-15 | Olin Mathieson | Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same |
JP3813644B2 (en) * | 1994-08-29 | 2006-08-23 | 英治 安里 | Bismuth complex and antibacterial agent containing the same |
US5928671A (en) * | 1995-04-25 | 1999-07-27 | Winthrop University Hospital | Method and composition for inhibiting bacteria |
US6086921A (en) * | 1995-04-25 | 2000-07-11 | Wintrop-University Hospital | Metal/thiol biocides |
US6017936A (en) * | 1997-03-14 | 2000-01-25 | Arch Chemicals, Inc. | Method for producing particles of pyrithione salts and particles so produced |
US5999828A (en) * | 1997-03-19 | 1999-12-07 | Qualcomm Incorporated | Multi-user wireless telephone having dual echo cancellers |
AU2003204105B2 (en) * | 1997-10-28 | 2005-11-17 | Winthrop-University Hospital | Metal/Thiol Biocides |
AU2656799A (en) * | 1998-02-04 | 1999-08-23 | Winthrop-University Hospital | Metal-thiols as imminomodulating agents |
US6465015B1 (en) * | 1998-02-24 | 2002-10-15 | Arch Chemicals, Inc. | Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles |
TWI245763B (en) * | 1998-04-02 | 2005-12-21 | Janssen Pharmaceutica Nv | Biocidal benzylbiphenyl derivatives |
CA2345231C (en) * | 1998-09-23 | 2009-12-22 | Phycogen, Inc. | Pharmaceutical compositions comprising derivatives of sulphur acids |
US6682724B2 (en) * | 1999-02-23 | 2004-01-27 | Arch Chemcials, Inc. | Sonic method of enhancing chemical reactions to provide uniform, non-agglomerated particles |
US6630172B2 (en) * | 2001-01-22 | 2003-10-07 | Kareem I. Batarseh | Microbicidal composition containing potassium sodium tartrate |
US6582719B2 (en) * | 2001-02-02 | 2003-06-24 | The Trustees Of Columbia University In The City Of New York | Combinations of antiseptic and antibiotic agents that inhibit the development of resistant microorganisms |
JP4357166B2 (en) * | 2002-10-21 | 2009-11-04 | 日揮触媒化成株式会社 | Antibacterial / antifungal / algae-proof composition |
WO2008043175A1 (en) * | 2006-10-13 | 2008-04-17 | Kane Biotech Inc. | SOLUBLE β-N-ACETYLGLUCOSAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
US7381751B2 (en) * | 2003-08-26 | 2008-06-03 | Shantha Sarangapani | Antimicrobial composition for medical articles |
CA2584122C (en) * | 2004-10-25 | 2013-04-30 | Polyzenix Gmbh | Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
JP4568232B2 (en) * | 2006-01-06 | 2010-10-27 | 秀和 西松 | Artificial bone head holder |
JP2007332040A (en) * | 2006-06-12 | 2007-12-27 | Shinshu Univ | Microbicide containing carbon nanotube and material and pharmaceutical preparation using the same |
WO2008092011A2 (en) * | 2007-01-24 | 2008-07-31 | Cook Incorporated | Biofilm-inhibiting medical products |
US8343536B2 (en) * | 2007-01-25 | 2013-01-01 | Cook Biotech Incorporated | Biofilm-inhibiting medical products |
CA2687628A1 (en) * | 2007-05-18 | 2008-11-27 | Agion Technologies, Inc. | Bioactive agrichemical compositions and use thereof |
US8895047B2 (en) * | 2007-06-01 | 2014-11-25 | Arrow International, Inc. | Combined fibrinolytic and antimicrobial catheter and uses thereof |
JP2010534266A (en) * | 2007-07-25 | 2010-11-04 | セロノバ バイオサイエンシーズ, インコーポレイテッド | Color-coded, size-sorted, fillable polymer particles for therapeutic and / or diagnostic applications, and methods for preparing and using them |
US8389021B2 (en) * | 2009-02-03 | 2013-03-05 | Microbion Corporation | Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications |
KR20200015814A (en) | 2010-02-03 | 2020-02-12 | 마이크로비온 코포레이션 | Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
-
2011
- 2011-02-03 KR KR1020207003093A patent/KR20200015814A/en not_active Application Discontinuation
- 2011-02-03 MX MX2016010269A patent/MX371047B/en unknown
- 2011-02-03 KR KR1020177034637A patent/KR101966867B1/en active IP Right Grant
- 2011-02-03 BR BR112012019286A patent/BR112012019286A2/en not_active Application Discontinuation
- 2011-02-03 KR KR1020197009488A patent/KR102074444B1/en active IP Right Grant
- 2011-02-03 KR KR1020127022562A patent/KR101821833B1/en active IP Right Grant
- 2011-08-11 JP JP2013524237A patent/JP2013535506A/en active Pending
- 2011-08-11 AU AU2011289338A patent/AU2011289338B2/en not_active Ceased
- 2011-08-11 CN CN201610127111.8A patent/CN105766990B/en active Active
- 2011-08-11 SG SG10201506131RA patent/SG10201506131RA/en unknown
- 2011-08-11 NZ NZ606634A patent/NZ606634A/en not_active IP Right Cessation
- 2011-08-11 UA UAA201303059A patent/UA113616C2/en unknown
- 2011-08-11 KR KR1020187019857A patent/KR20180085042A/en active Search and Examination
- 2011-08-11 SG SG2013010053A patent/SG187801A1/en unknown
- 2011-08-11 WO PCT/US2011/047490 patent/WO2012021754A2/en active Application Filing
- 2011-08-11 CA CA2807993A patent/CA2807993C/en active Active
- 2011-08-11 RU RU2018108411A patent/RU2018108411A/en not_active Application Discontinuation
- 2011-08-11 RU RU2013110493/10A patent/RU2013110493A/en not_active Application Discontinuation
- 2011-08-11 SG SG10202001032RA patent/SG10202001032RA/en unknown
- 2011-08-11 BR BR112013003127A patent/BR112013003127A2/en not_active Application Discontinuation
- 2011-08-11 CN CN201180042863.XA patent/CN103096720B/en active Active
- 2011-08-11 KR KR1020137006121A patent/KR20130132410A/en not_active Application Discontinuation
- 2011-08-11 MX MX2013001581A patent/MX362785B/en active IP Right Grant
- 2011-08-11 EP EP11817067.9A patent/EP2603083A4/en not_active Withdrawn
-
2012
- 2012-08-03 MX MX2019010863A patent/MX2019010863A/en unknown
-
2013
- 2013-02-08 MX MX2019001293A patent/MX2019001293A/en unknown
- 2013-02-12 IL IL224684A patent/IL224684A/en active IP Right Grant
- 2013-02-12 CL CL2013000430A patent/CL2013000430A1/en unknown
-
2016
- 2016-01-08 JP JP2016003005A patent/JP6272366B2/en active Active
- 2016-05-26 AU AU2016203475A patent/AU2016203475A1/en not_active Abandoned
- 2016-10-21 IL IL248446A patent/IL248446B/en active IP Right Grant
- 2016-12-14 PH PH12016502498A patent/PH12016502498A1/en unknown
-
2017
- 2017-07-21 JP JP2017141774A patent/JP2018008971A/en active Pending
- 2017-10-10 CL CL2017002549A patent/CL2017002549A1/en unknown
- 2017-12-28 JP JP2017253007A patent/JP6685991B2/en active Active
-
2018
- 2018-04-24 IL IL258908A patent/IL258908A/en unknown
- 2018-06-13 AU AU2018204190A patent/AU2018204190B2/en active Active
-
2019
- 2019-12-03 JP JP2019219070A patent/JP7097344B2/en active Active
- 2019-12-13 JP JP2019225544A patent/JP2020063277A/en active Pending
-
2021
- 2021-10-08 JP JP2021166416A patent/JP2022003090A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017002549A1 (en) | Use of a bismuth-thiol (bt) composition, which is used to prepare a medication useful for the treatment of an open wound that has or is at risk of having a bacterial biofilm infection. | |
CY1123901T1 (en) | PHARMACEUTICAL COMPOSITION AND ADMINISTRATION THEREOF | |
CL2017001191A1 (en) | Compounds derived from polycyclic carbamoylpyridone; pharmaceutical composition comprising them; and its use for the treatment of a hiv infection in a human who has or is at risk of having the infection. | |
CL2010000188A1 (en) | A method for treating an infection in a subject comprising the administration of 9 - [(2,2-dimethyl-propylamino) -methyl] -minocycline or a salt thereof; pharmaceutical composition comprising said compound; and its use. | |
BR112013011737A2 (en) | compound, use of a compound pharmaceutical composition, and method of treating or preventing an HIV infection | |
BRPI1013394A2 (en) | "compound, pharmaceutical composition, use of the compound, and method for treating a hepatitis c virus infected patient." | |
BR112014000665A2 (en) | compound, use thereof, pharmaceutical composition, antimicrobial agent, and method for preventing or treating a bacterial infection | |
BRPI0910368A2 (en) | "use of one or more enhancers chosen from biointensifiers and photo intensifiers, composition for use of one or more enhancers chosen from biointensifiers and photo intensifiers and eye drops for use of one or more intensifiers chosen from biointensifiers and photo intensifiers" | |
EA200970047A1 (en) | WATER SUSPENSIONS TMS278 | |
CL2012002489A1 (en) | Compounds derived from silyl naphtho-imidazole; pharmaceutical composition; and its use to prevent or treat a hepatitis c virus infection. | |
WO2013052958A3 (en) | Antimicrobial compositions and methods employing same | |
RU2010129238A (en) | APPLICATION OF ISOTHIOCYANATE DERIVATIVES AS ANTI-VEHICLES | |
BRPI0814593A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND. | |
HRP20110861T1 (en) | Drug for treatment of influenza | |
UY31145A1 (en) | DERIVED FROM 17B + CIANO-18A-HOMO-19-NOR-ANDROST-4-ENO, ITS USE AND MEDICATION CONTAINING IT | |
CR20190006A (en) | COMPOSITION AND CONTRIBUTION FOR WOUND TREATMENT | |
CL2012002716A1 (en) | Use of a dgat1 inhibitor compound because it is useful in the prevention, delay of progress or treatment of a disease or condition selected from chylomicronemia, familial chylomicronemia syndrome and type v hyperlipoproteinemia; a compound derived from substituted heteroaryl; pharmaceutical composition | |
EA201300258A1 (en) | COMPOSITIONS BASED ON NALBUFIN AND THEIR APPLICATION | |
BRPI0907892A2 (en) | Azatricyclic antibiotic compound, medicine, pharmaceutical composition containing and use thereof | |
CL2012003266A1 (en) | Tamarind seed polysaccharide for use in the treatment of microbial infections; pharmaceutical and / or antimicrobial dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide; method to treat and / or prevent a patient who has a microbial infection. | |
EA201170512A1 (en) | COMPOSITION FOR ORAL ADMINISTRATION | |
AR077139A1 (en) | PHARMACEUTICAL COMPOSITIONS USEFUL TO TREAT VCH | |
AR090569A1 (en) | AGGREGATES OF NANOPARTICLES CONTAINING OSTEOPONTIN AND PARTICLES CONTAINING CALCIUM AND / OR STRONTIUM | |
BRPI0916571A2 (en) | alkylaminomethyloxazolidinone tricyclic derivative compound, medicament and pharmaceutical composition containing it and use of the compound | |
CL2013002107A1 (en) | Use of an aqueous viscoelastic fluid to produce a medicinal product for the surgical treatment of the eye, comprising a) at least one polymer of viscosity increase at a concentration of 0.01-30%, b) a ph value that ranges from 6 to 8.5 and c) an osmolarity that ranges from 200 to 400 mosmol / l. |